Why is Symbiox Investme falling/rising?

As of 27-Jun, Symbiox Investment & Trading Co Ltd is experiencing a decline in its stock price, currently at 2.77, which reflects a decrease of 0.14 or 4.81%. The stock has underperformed its sector by 4.9% today and has been on a downward trend for the last two days, with a total decline of 10.06% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. While the stock has generated a modest return of 1.84% over the past year, it is facing challenges with operating losses and a weak long-term fundamental strength, as indicated by a low return on equity (ROE) of 0.6 and a price-to-book value of 0.3. The company's operating profit growth has been stagnant, contributing to a negative outlook.
In the broader market context, the stock's recent performance contrasts sharply with the Sensex, which has gained 2.00% over the past week and 3.07% over the past month. Year-to-date, Symbiox has seen a significant decline of 48.89%, while the Sensex has increased by 7.58%. This stark difference highlights the stock's struggles relative to the overall market, further compounded by the fact that the majority of its shareholders are non-institutional, which may indicate a lack of confidence among institutional investors. The combination of poor financial performance, declining stock price, and underperformance against the benchmark suggests that investor sentiment remains negative towards Symbiox Investment & Trading Co Ltd.